Clinical Trial Update: Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of drotrecogin alfa (activated) in adult septic shock patients; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Drotrecogin alfa (activated) (drotrecogin alfa (activated))

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sepsis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-18